retatrutide fda approval status november 2025 Is Approved? Current (2026) The FDA has issued warning

It showed significant effectiveness in phase 3 trials (ATTAIN-1), reducing body weight by approximately 12.4% (about 27 pounds) at the highest dose (17.2 mg) over 72 weeks

Supplement distributors can confidently position AdvaLife supplements as safe, effective, and aligned with international standards

Keep it realistic: Half-dosing might save a few bucks in the short term, but if you lose the meds full benefits, you might end up back at square one

Its physiology. Snyder recommends that GLP-1 users, especially those who are fairly new to them or are not seeing the expected results after a certain period of time, stay in close contact with their prescribers

Continue pushing for similar weights and rep ranges on compound movements